Jardiance and Farxiga Gangrene Lawsuit

Q: Has there been a recall of these drugs?

Neither Jardiance or Farxiga have been recalled. The FDA's warning required manufacturers to add warnings about Fournier's gangrene to the prescribing information of SGLT2 inhibitors, but did not go as far as recalling the drugs from the market.

We are no longer accepting further cases for this lawsuit.

If you or a loved one contracted Fournier's Gangrene after taking Jardiance or Farxiga, you may be entitled to compensation. Contact the Kishish Law Group today for your free and confidential case evaluation by calling us toll free at 1 (888) 609-4664 or by completing our contact form.

In August 2018, the U.S. Food and Drug Administration (FDA) issued a warning that some type 2 diabetes drugs had been associated with a serious infection of the genital area called Fournier's gangrene. On the FDA's list were Jardiance (empagliflozin) and Farxiga (dapagliflozin). The FDA identified 12 cases over five years where patients taking these or other related drugs developed Fournier's gangrene. All 12 patients required hospitalization and surgery. One patient died. Fournier's gangrene is usually much rarer. The FDA remarked that in studies of other drugs, they had only observed 6 cases of the disease over a period of more than 30 years.

If you or a loved one suffered from Fournier's gangrene after taking Jardiance or Farxiga, joining a lawsuit against the pharmaceutical companies can help you pay for medical bills, lost wages, and other costs associated with problems caused by these drugs. Lawsuits can also send a strong signal to these companies that they should not be able to profit off of the pain and suffering of the people their drugs are supposed to help. In the last three months of 2018 alone, Jardiance and Farxiga sales reached nearly $1.5 billion. Join a lawsuit today to tell these companies that they must test their drugs more completely before releasing them on the market.

What are Jardiance and Farxiga?

Jardiance and Farxiga are drugs commonly prescribed to treat diabetes. These drugs are part of a class of drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors. Drugs like Jardiance, Farxiga, Invokana, and Steglatro, among others, cause the kidneys to remove sugar in the body by expelling it in the urine.

For many patients the drugs have a safe track record and can be part of a successful treatment regimen for type 2 diabetes. But these drugs can have serious adverse effects as well. Earlier post-market reporting revealed that these drugs can cause an increased risk of ketoacidosis, infections and amputations. In June 2019, research published in the Annals of Internal Medicine showed that these drugs were also associated with an increased risk of developing Fournier's gangrene.

What are the symptoms of Fournier's gangrene?

Fournier's gangrene is a form of necrotizing fasciitis, popularly known as "flesh-eating disease," that affects the genital area. Early symptoms of Fournier's gangrene may include:

Genital pain
Tenderness, redness, or swelling of the genitals or the area between the genitals and rectum
Fever
General feeling of unwellness

The FDA has warned that these symptoms may worsen quickly. If you are taking an SGLT2 inhibitor and experience these symptoms, the FDA advises that you should seek medical attention immediately. Gangrene can cause permanent scarring and may require reconstructive surgery. Left untreated for too long, gangrene may require amputation of the affected areas or spread to your organs and may be fatal.

Has there been a recall of these drugs?

Neither Jardiance or Farxiga have been recalled. The FDA's warning required manufacturers to add warnings about Fournier's gangrene to the prescribing information of SGLT2 inhibitors, but did not go as far as recalling the drugs from the market.

What do the lawsuits say?

Most Jardiance and Farxiga lawsuits claim that the manufacturers failed to warn about the increased risk of developing a flesh-eating disease. Pharmaceutical companies have a duty to stay informed about the products they sell. If a pharmaceutical company failed to warn about a side effect of a drug, and that side effect could have been reasonably discovered through testing the drug, the company may be held responsible for the damage caused to patients that took the drug.

Do I have a Jardiance or Farxiga lawsuit?

Contacting a lawyer is the best way to determine your legal options. Everyone's case is different. An experienced lawyer is in the best position to help you decide your legal path forward. The Kishish Law Group's attorneys and staff will listen to your story and help guide you through your options. Our consultations are free and confidential. If you think you or a loved one may have a Jardiance or Farxiga lawsuit, contact us today by calling us toll free at 1 (888) 609-4664 or by completing our contact form.

Last Modified: May 21, 2022

DISCLAIMER: No attorney client relationship will exist between you and our firm until we enter into a signed Retainer/Services Agreement. Completion of this document is for informational purposes only and does not constitute a Retainer/Services Agreement. The information you obtain at this site is not, nor is it intended to be, legal advice. Contacting us does not create an attorney-client relationship. In some jurisdictions this website may be considered lawyer advertising. You should consult an attorney for advice regarding your individual situation. Click here for more information.